 Allergan Inc has filed a federal lawsuit challenging the legality of Valeant Pharmaceuticals International Incs joint takeover bid with investor William Ackman saying their pursuit of the company violated securities laws meant to prevent investors from profiting from inside information Valeant and Mr Ackmans Pershing Square Capital Management LP are both defendants in the suit They unveiled their bid in April after Pershing Square bought about  of Allergan After being rebuffed by Allergans board they launched
  